TY - JOUR
T1 - Validation of an obstetric fistula screening questionnaire
T2 - a case–control study with clinical examination
AU - Chen, Chi Chiung Grace
AU - Long, Annelise
AU - Rwabizi, Denis
AU - Mbabazi, Gerard
AU - Ndizeye, Ntwali
AU - Dushimiyimana, Blaise
AU - Ngoga, Eugene
N1 - Funding Information:
This work was funded by the Maren Foundation and the Johns Hopkins Center for Global Health.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Background: Obstetric fistula (OF) is a significant cause of maternal morbidity in lower resource settings where women experience obstructed labor without timely access to skilled obstetric care. The true prevalence of OF is unknown; however, it is estimated to affect 2 to 3.5 million women globally. The Demographic and Health Surveys’ (DHS) Fistula Module includes the OF symptom questions most frequently used for prevalence estimates, but these questions have not been validated. The aim of this study is to validate a symptom-based screening questionnaire for OF, including a question in the DHS’ Fistula Module. Methods: With an international panel of fistula surgeons, we developed and face-validated a screening questionnaire that assessed for symptoms of lower urinary tract fistula (LUTF) and lower gastrointestinal tract fistula (LGTF), as well as urinary and fecal incontinence (UI, FI). We evaluated the discriminative ability of the questionnaire using a case–control study design in a 1:2:2 ratio: cases were parous women with fistula confirmed on examination, controls included parous women without fistula on examination, with and without UI symptoms. All women underwent screening for fistula symptoms and a physical examination, with examiners blinded to screening results. Results: Of the 367 Rwandan women who completed the questionnaires and underwent clinical examination, 59 women had LUTFs and 34 had LGTFs, 274 women were classified as controls with and without symptoms of UI. All LUTF screening questions performed well, including the DHS fistula question. The combination of two LUTF screening questions had the highest sensitivity (100%; 95% CI 94%, 100%), specificity (96%; 95% CI 93%, 98%), and area under the curve (AUC) (0.98). The combination of a LGTF screening question and FI question demonstrated the highest sensitivity (97%; 95% CI 85%, 100%), specificity (98%; 95% CI 95%, 99%) and AUC (0.98). Conclusions: Our OF screening questionnaire, including the DHS fistula question, demonstrated high sensitivities, specificities, and AUC.
AB - Background: Obstetric fistula (OF) is a significant cause of maternal morbidity in lower resource settings where women experience obstructed labor without timely access to skilled obstetric care. The true prevalence of OF is unknown; however, it is estimated to affect 2 to 3.5 million women globally. The Demographic and Health Surveys’ (DHS) Fistula Module includes the OF symptom questions most frequently used for prevalence estimates, but these questions have not been validated. The aim of this study is to validate a symptom-based screening questionnaire for OF, including a question in the DHS’ Fistula Module. Methods: With an international panel of fistula surgeons, we developed and face-validated a screening questionnaire that assessed for symptoms of lower urinary tract fistula (LUTF) and lower gastrointestinal tract fistula (LGTF), as well as urinary and fecal incontinence (UI, FI). We evaluated the discriminative ability of the questionnaire using a case–control study design in a 1:2:2 ratio: cases were parous women with fistula confirmed on examination, controls included parous women without fistula on examination, with and without UI symptoms. All women underwent screening for fistula symptoms and a physical examination, with examiners blinded to screening results. Results: Of the 367 Rwandan women who completed the questionnaires and underwent clinical examination, 59 women had LUTFs and 34 had LGTFs, 274 women were classified as controls with and without symptoms of UI. All LUTF screening questions performed well, including the DHS fistula question. The combination of two LUTF screening questions had the highest sensitivity (100%; 95% CI 94%, 100%), specificity (96%; 95% CI 93%, 98%), and area under the curve (AUC) (0.98). The combination of a LGTF screening question and FI question demonstrated the highest sensitivity (97%; 95% CI 85%, 100%), specificity (98%; 95% CI 95%, 99%) and AUC (0.98). Conclusions: Our OF screening questionnaire, including the DHS fistula question, demonstrated high sensitivities, specificities, and AUC.
KW - Pelvic organ prolapse
KW - Prevalence
KW - Rectovaginal fistula
KW - Sensitivity
KW - Specificity
KW - Symptom-based screening questionnaire
KW - Vesicovaginal fistula
UR - http://www.scopus.com/inward/record.url?scp=85123104720&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85123104720&partnerID=8YFLogxK
U2 - 10.1186/s12978-021-01317-2
DO - 10.1186/s12978-021-01317-2
M3 - Article
C2 - 35042512
AN - SCOPUS:85123104720
SN - 1742-4755
VL - 19
JO - Reproductive health
JF - Reproductive health
IS - 1
M1 - 12
ER -